Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
Open Access
- 2 March 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Human Vaccines & Immunotherapeutics
- Vol. 16 (8), 1866-1874
- https://doi.org/10.1080/21645515.2019.1709352
Abstract
With more demand for Sabin inactivated poliovirus vaccines (sIPVs) to support the global polio eradication effort worldwide, data regarding the potency characteristics of sIPV after exposure to freezing temperatures are urgently required. In the present study, the sIPVs were stored at −20°C for 24 h, 1 week, and 2 weeks in the freezer or in a vaccine carrier for 1 or 3 freeze-thaw cycle to evaluate the effect mediated by freezing temperatures that may be encountered during routine storage and transfer. The in vitro potency was then determined by a D-antigen enzyme-linked immunosorbent assay, and the in vivo potency was evaluated in Wistar rats. In the in vitro study for freezer storage groups, the D-antigen contents for all three types decreased and were lower than the release specifications after storing at −20°C for 2 weeks. After storing at −20°C for 1 week, the D-antigen contents for types I and III in combined group of a total of 45 vials, and for type II in the specific lot groups containing 15 vials decreased, but were within the release specifications. Moreover, no significant change in in vivo potency was observed. For vaccine carrier transfer groups, the D-antigen contents did not decrease after 1 freeze-thaw cycle; in contrast, it decreased, but no significant in vivo potency loss was observed after 3 freeze-thaw cycles. These results suggest that it may be possible to retain sufficient sIPV potency after short periods of freezing or freeze-thawing during transport.Keywords
Funding Information
- National Health Commission of the People’s Republic of China (2018ZX09737-003)
- Special Funds for high-level Health Talents of Yunnan Province (L-2017003)
- CAMS Initiative for Innovative Medicine (2017-I2M-B&R-016)
- Yunnan Provincial Science and Technology Department (2019HC006 and 20172F008, 2016ZF003, 2019HC006, 20172F008)
This publication has 14 references indexed in Scilit:
- Monitoring Results in Routine Immunization: Development of Routine Immunization Dashboard in Selected African Countries in the Context of the Polio Eradication Endgame Strategic PlanThe Journal of Infectious Diseases, 2017
- Is freezing in the vaccine cold chain an ongoing issue? A literature reviewVaccine, 2017
- Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010–2014Vaccine, 2017
- ErratumJournal of Toxicologic Pathology, 2016
- Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, CameroonBMC Research Notes, 2015
- Polio Virus Neutralizing Antibody Dynamics Among Children in a North-Central and South-Western Nigeria StateJournal of Immunoassay and Immunochemistry, 2014
- Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled TrialThe Journal of Infectious Diseases, 2011
- Characterization of the freeze sensitivity of a hepatitis B vaccineHuman Vaccines, 2009
- Freezing temperatures in the vaccine cold chain: A systematic literature reviewVaccine, 2007
- [Determination of polio-neutralizing antibody by the micro-tissue culture technic].1985